Ligand validation:3HMO

7PE: 2-(2-(2-(2-(2-(2-ETHOXYETHOXY)ETHOXY)ETHOXY)ETHOXY)ETHOXY)ETHANOL

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
3HMO_7PE_A_1153	11%	88%	0.269	0.825	0.5	0.17	-	-	0	0	76%	0.7619
3GFW_7PE_A_809	41%	46%	0.174	0.93	0.79	1.29	-	3	3	0	76%	0.7619
5EHY_7PE_A_907	39%	63%	0.169	0.92	0.66	0.77	-	-	4	0	76%	0.7619
4BHZ_7PE_A_1795	16%	67%	0.319	0.933	0.62	0.65	-	-	1	0	76%	0.7619
3AHX_7PE_D_4002	69%	53%	0.106	0.921	0.67	1.15	-	1	5	0	100%	1
2OVJ_7PE_A_5096	57%	52%	0.116	0.935	0.86	0.98	1	1	0	0	76%	0.7619
4KTR_7PE_D_808	55%	44%	0.172	0.94	0.73	1.43	-	3	3	0	100%	1
3A3U_7PE_A_501	35%	73%	0.17	0.857	0.54	0.5	-	-	1	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.